Joni W. Lam

809 total citations
7 papers, 532 citations indexed

About

Joni W. Lam is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Joni W. Lam has authored 7 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Oncology. Recurrent topics in Joni W. Lam's work include Cell death mechanisms and regulation (4 papers), Cardiac electrophysiology and arrhythmias (2 papers) and RNA and protein synthesis mechanisms (2 papers). Joni W. Lam is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Cardiac electrophysiology and arrhythmias (2 papers) and RNA and protein synthesis mechanisms (2 papers). Joni W. Lam collaborates with scholars based in United States. Joni W. Lam's co-authors include Thomas O’Brien, Jeanne A. Hardy, Jack Nguyen, James A. Wells, Matthew Burdett, Warren L. DeLano, Dennis Lee, Ingrid Choong, Eric M. Gordon and Daniel A. Erlanson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Journal of Medicinal Chemistry.

In The Last Decade

Joni W. Lam

7 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joni W. Lam United States 7 421 145 113 102 80 7 532
Steffen Lang Germany 13 478 1.1× 110 0.8× 107 0.9× 147 1.4× 95 1.2× 19 667
Thomas P. Matthews United Kingdom 12 400 1.0× 163 1.1× 128 1.1× 113 1.1× 58 0.7× 21 561
Malcolm Anderson United Kingdom 9 341 0.8× 90 0.6× 60 0.5× 117 1.1× 83 1.0× 12 484
Corey L. Strickland United States 10 434 1.0× 193 1.3× 68 0.6× 156 1.5× 76 0.9× 22 609
Michele F. Rega United States 17 502 1.2× 137 0.9× 90 0.8× 92 0.9× 36 0.5× 28 762
Henriëtte M. G. Willems United Kingdom 13 317 0.8× 200 1.4× 91 0.8× 157 1.5× 42 0.5× 24 512
Laxman Nallan United States 11 285 0.7× 137 0.9× 71 0.6× 57 0.6× 68 0.8× 11 544
K. Boxall United Kingdom 8 444 1.1× 90 0.6× 89 0.8× 168 1.6× 87 1.1× 11 542
Jürgen Dinges United States 11 431 1.0× 249 1.7× 141 1.2× 54 0.5× 24 0.3× 16 667
Sameh Eid Egypt 10 355 0.8× 201 1.4× 171 1.5× 65 0.6× 28 0.3× 16 647

Countries citing papers authored by Joni W. Lam

Since Specialization
Citations

This map shows the geographic impact of Joni W. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joni W. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joni W. Lam more than expected).

Fields of papers citing papers by Joni W. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joni W. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joni W. Lam. The network helps show where Joni W. Lam may publish in the future.

Co-authorship network of co-authors of Joni W. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Joni W. Lam. A scholar is included among the top collaborators of Joni W. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joni W. Lam. Joni W. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Belmont, Brian J., Marc Evanchik, W. Michael Flanagan, et al.. (2009). SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo. Cancer Chemotherapy and Pharmacology. 65(4). 707–717. 53 indexed citations
2.
O’Brien, Thomas, Bruce J. Fahr, Joni W. Lam, et al.. (2005). Structural analysis of caspase-1 inhibitors derived from Tethering. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 61(5). 451–458. 16 indexed citations
3.
Fahr, Bruce J., Thomas O’Brien, Nathan D. Waal, et al.. (2005). Tethering identifies fragment that yields potent inhibitors of human caspase-1. Bioorganic & Medicinal Chemistry Letters. 16(3). 559–562. 19 indexed citations
4.
Hardy, Jeanne A., Joni W. Lam, Jack Nguyen, Thomas O’Brien, & James A. Wells. (2004). Discovery of an allosteric site in the caspases. Proceedings of the National Academy of Sciences. 101(34). 12461–12466. 188 indexed citations
5.
Erlanson, Daniel A., Joni W. Lam, Christian Wiesmann, et al.. (2003). In situ assembly of enzyme inhibitors using extended tethering. Nature Biotechnology. 21(3). 308–314. 155 indexed citations
6.
Allen, Darin A., Ingrid Choong, Bruce J. Fahr, et al.. (2003). Identification of potent and novel small-Molecule inhibitors of caspase-3. Bioorganic & Medicinal Chemistry Letters. 13(21). 3651–3655. 18 indexed citations
7.
Choong, Ingrid, Willard Lew, Dennis Lee, et al.. (2002). Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design. Journal of Medicinal Chemistry. 45(23). 5005–5022. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026